Abingworth as of Sept. 30, 2022
Portfolio Holdings for Abingworth
Abingworth holds 19 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vaxcyte (PCVX) | 34.2 | $100M | 4.2M | 24.00 | |
| Vera Therapeutics Cl A (VERA) | 21.6 | $63M | 3.0M | 21.31 | |
| Hillevax | 10.7 | $31M | 1.8M | 17.08 | |
| Adicet Bio (ACET) | 10.3 | $30M | 2.1M | 14.19 | |
| Verona Pharma Sponsored Ads (VRNA) | 8.6 | $25M | 2.5M | 10.21 | |
| Phathom Pharmaceuticals (PHAT) | 5.4 | $16M | 1.4M | 11.08 | |
| Reneo Pharmaceuticals (RPHM) | 2.4 | $6.9M | 2.1M | 3.35 | |
| Jasper Therapeutics | 1.5 | $4.4M | 5.6M | 0.79 | |
| Nucana Sponsored Adr | 1.2 | $3.4M | 3.3M | 1.02 | |
| Effector Therapeutics | 0.9 | $2.7M | 4.8M | 0.57 | |
| Paratek Pharmaceuticals | 0.9 | $2.7M | 1.0M | 2.57 | |
| Spruce Biosciences (SPRB) | 0.8 | $2.5M | 1.8M | 1.38 | |
| Soleno Therapeutics (SLNO) | 0.7 | $2.0M | 1.2M | 1.67 | |
| Sientra | 0.4 | $1.1M | 1.7M | 0.64 | |
| Cymabay Therapeutics | 0.2 | $457k | 131k | 3.49 | |
| Exicure Com New | 0.2 | $439k | 282k | 1.56 | |
| Molecular Templates | 0.1 | $150k | 200k | 0.75 | |
| Aeglea Biotherapeutics | 0.0 | $127k | 241k | 0.53 | |
| Obseva Sa | 0.0 | $13k | 88k | 0.15 |
